Published on: 08/15/2023 11:58 AM
[[VIEW_THIS]]
|
|
|
Register now for the BCP hybrid Customer Partnership Meeting September 7
|
Register today to attend the United States Patent and Trademark Office’s (USPTO) next Biotechnology, Chemical, and Pharmaceutical (BCP) Customer Partnership Meeting, on Thursday, September 7, from 10 a.m. to 5 p.m. ET. The hybrid meeting will be held in person at the USPTO headquarters in Alexandria, Virginia, and online.
BCP meetings are part of a long-standing partnership between the USPTO and its valued stakeholders that works to improve the quality of the agency’s products and services. The meeting’s discussion topics include:
- Summary of Amgen v. Sanofi
- 35 U.S.C. § 112(a)
- Re-examination
- Best practices to help growth-stage companies build their IP portfolio
- Patent Center and DOCX
- Common sequence compliance errors
The USPTO looks forward to hearing the individual views of its customers and does not intend to use this forum to seek or arrive at any consensus advice.
Advanced registration is required. Once registered, you will be emailed instructions for joining the BCP.
For more information or to request a reasonable accommodation, please email USPTOBCP1600@USPTO.GOV. Captioning service will be provided.
|
|
|
Stay connected with the USPTO by subscribing to regular email updates.
Visit our subscription center at www.uspto.gov/subscribe to update or change your email preferences.
This email was sent from an unmonitored mailbox. To contact us, please visit our website www.uspto.gov/about/contacts. To ensure that you continue to receive our news and notices, please modify your email filters to allow mail from subscriptioncenter@subscriptions.uspto.gov.
|
|
|
|
|